Charles Schwab’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $269M | Sell |
|
|||||
|
2025
Q2 | $316M | Buy |
|
|||||
|
2025
Q1 | $286M | Buy |
|
|||||
|
2024
Q4 | $279M | Buy |
|
|||||
|
2024
Q3 | $241M | Buy |
|
|||||
|
2024
Q2 | $333M | Buy |
|
|||||
|
2024
Q1 | $342M | Buy |
|
|||||
|
2023
Q4 | $263M | Buy |
|
|||||
|
2023
Q3 | $239M | Buy |
|
|||||
|
2023
Q2 | $315M | Buy |
|
|||||
|
2023
Q1 | $276M | Buy |
|
|||||
|
2022
Q4 | $244M | Buy |
|
|||||
|
2022
Q3 | $260M | Sell |
|
|||||
|
2022
Q2 | $300M | Buy |
|
|||||
|
2022
Q1 | $366M | Buy |
|
|||||
|
2021
Q4 | $392M | Buy |
|
|||||
|
2021
Q3 | $333M | Buy |
|
|||||
|
2021
Q2 | $298M | Buy |
|
|||||
|
2021
Q1 | $239M | Sell |
|
|||||
|
2020
Q4 | $285M | Sell |
|
|||||
|
2020
Q3 | $268M | Sell |
|
|||||
|
2020
Q2 | $237M | Buy |
|
|||||
|
2020
Q1 | $205M | Buy |
|
|||||
|
2019
Q4 | $248M | Buy |
|
|||||
|
2019
Q3 | $216M | Buy |
|
|||||
|
2019
Q2 | $178M | Sell |
|
|||||
|
2019
Q1 | $188M | Buy |
|
|||||
|
2018
Q4 | $128M | Buy |
|
|||||
|
2018
Q3 | $142M | Buy |
|
|||||
|
2018
Q2 | $116M | Buy |
|
|||||
|
2018
Q1 | $107M | Buy |
|
|||||
|
2017
Q4 | $81.6M | Buy |
|
|||||
|
2017
Q3 | $76M | Buy |
|
|||||
|
2017
Q2 | $77.9M | Buy |
|
|||||
|
2017
Q1 | $60.1M | Buy |
|
|||||
|
2016
Q4 | $56.7M | Sell |
|
|||||
|
2016
Q3 | $77.3M | Buy |
|
|||||
|
2016
Q2 | $59.6M | Sell |
|
|||||
|
2016
Q1 | $53.7M | Buy |
|
|||||
|
2015
Q4 | $47.5M | Buy |
|
|||||
|
2015
Q3 | $40.7M | Sell |
|
|||||
|
2015
Q2 | $47.3M | Sell |
|
|||||
|
2015
Q1 | $56.2M | Sell |
|
|||||
|
2014
Q4 | $52.4M | Buy |
|
|||||
|
2014
Q3 | $39.4M | Buy |
|
|||||
|
2014
Q2 | $21.1M | Buy |
|
|||||
|
2014
Q1 | $17.8M | Buy |
|
|||||
|
2013
Q4 | $15.6M | Buy |
|
|||||
|
2013
Q3 | $16.2M | Buy |
|
|||||
|
2013
Q2 | $14.8M | Buy |
|